Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

GDR Labs CONOCB2 is a groundbreaking natural pain relief supplement designed to help individuals manage discomfort without ...

Womens: Other research has found men and women spend similar amounts on health care overall, or even that men spend a little ...

WH testers have confirmed there’s a reason these sneakers have thousands of five-star reviews on multiple sites. As Tina ...